Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis
Open Access
- 7 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 16 (3), 308-312
- https://doi.org/10.1038/nm.2098
Abstract
Osteoporosis results from misregulation of bone catabolism and bone anabolism, resulting in severe bone loss. Most current therapies act by decreasing bone catabolism, but targeting bone anabolism is more desired, because once bone is lost, it is difficult to replace. In a new report by Gerard Karsenty and his colleagues, they show that orally delivered pharmacological targeting of serotonin synthesis in the gut is sufficient to increase bone anabolism and thus restore lost bone in rat and mouse models of well-established osteoporosis ( pages 264–265 ). Osteoporosis is a disease of low bone mass most often caused by an increase in bone resorption that is not sufficiently compensated for by a corresponding increase in bone formation1. As gut-derived serotonin (GDS) inhibits bone formation2, we asked whether hampering its biosynthesis could treat osteoporosis through an anabolic mechanism (that is, by increasing bone formation). We synthesized and used LP533401, a small molecule inhibitor of tryptophan hydroxylase-1 (Tph-1), the initial enzyme in GDS biosynthesis. Oral administration of this small molecule once daily for up to six weeks acts prophylactically or therapeutically, in a dose–dependent manner, to treat osteoporosis in ovariectomized rodents because of an isolated increase in bone formation. These results provide a proof of principle that inhibiting GDS biosynthesis could become a new anabolic treatment for osteoporosis.Keywords
This publication has 24 references indexed in Scilit:
- A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy ExpenditureCell, 2009
- Effects of Parathyroid Hormone and Alendronate Alone or in Combination in OsteoporosisThe New England Journal of Medicine, 2004
- Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposureBone, 2003
- Leptin Regulates Bone Formation via the Sympathetic Nervous SystemCell, 2002
- Three-Dimensional Structure of Human Tryptophan Hydroxylase and Its Implications for the Biosynthesis of the Neurotransmitters Serotonin and Melatonin,Biochemistry, 2002
- Sex Steroids and BoneProceedings of the 1972 Laurentian Hormone Conference, 2002
- Maintenance of Serotonin in the Intestinal Mucosa and Ganglia of Mice that Lack the High-Affinity Serotonin Transporter: Abnormal Intestinal Motility and the Expression of Cation TransportersJournal of Neuroscience, 2001
- Therapeutic Approaches to Bone DiseasesScience, 2000
- Leptin Inhibits Bone Formation through a Hypothalamic Relay: A Central Control of Bone MassCell, 2000
- The direct examination of three-dimensional bone architecture in vitro by computed tomographyJournal of Bone and Mineral Research, 1989